- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06880068
Reliability and Validity of DIDA-Q in Parkinson's Disease
March 11, 2025 updated by: Marmara University
Validity and Reliability of the Dual Task Impact on Daily Living Questionnaire in Patients with Parkinson's Disease
The aim of our study is to investigate the validity and reliability of the Dual Task Impact on Daily-living Activities (DIDA-Q) to assess the degree of difficulty felt when performing dual tasks during activities of daily living in patients with Parkinson's disease.
In our study, the validity and reliability of a questionnaire to assess the degree of difficulty felt while performing dual tasks during activities of daily living in Parkinson's Disease will be examined for the first time.
The study will include 95 participants with Hoehn-Yahr Stage 1-3, diagnosed with Idiopathic Parkinson's Disease and able to walk 10 metres without an assistive device.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Dual task ability is defined as the ability to perform two activities simultaneously .
It is known that the ability to perform a motor or cognitive secondary activity at the same time during walking (talking to a person next to you while walking or carrying objects while walking) leads to gait and balance problems of different severity depending on the type of secondary task in Parkinson's Disease (PD).
When patients with Parkinson's Disease (pwPD) are exposed to dual-task walking, their walking speed and length of stride decrease, and the frequency of freezing phenomena during walking increases.
Consequently the risk of falling increase during activities of daily living.
Individuals often perform dual tasks while performing activities of daily living because of the nature of the tasks' requirements.
Therefore, it has become important to evaluate dual task performance in order to create the right treatment plan in the field of neurological physiotherapy and rehabilitation.
Although dual task performance is evaluated with different formulae in the literature, the number of scales evaluating the level of difficulty perceived by the patient during the performance of activities of daily living under dual task is limited.
The validity of the existing scales for PD has not been studied.
The Dual-task Impact on Daily-living Activities Questionnaire (DIDA-Q) is a patient-reported questionnaire developed to assess the degree of difficulty perceived when performing dual tasks during activities of daily living.
Study Type
Observational
Enrollment (Actual)
95
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Çapa
-
Istanbul, Çapa, Turkey
- Istanbul University, Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients who diagnosed with Parkinson's disease were included.
Description
Inclusion Criteria:
- Diagnosed with Idiopathic Parkinson's Disease according to UK Brain Bank criteria
- Walking at least 10 metres without an assistive device
- To have the cognitive capability to understand and answer the questions asked in the scale
Exclusion Criteria:
- Having any neurological disease other than idiopathic Parkinson's Disease
- The person has an orthopaedic or cardiopulmonary disease that affects walking
- Severe hearing-visual impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DIDA-Q
Time Frame: 1 week
|
Dual Task Impact on Daily-living Activities Questionnaire, higher scores means bad dual task performance
|
1 week
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Six Spot Step Test cognitive
Time Frame: 1 week
|
Designed to assess motor-cognitive dual task performance.
|
1 week
|
|
Dual Task Interference
Time Frame: 1 week
|
It is calculating with a formula which contain single and dual task performance.
|
1 week
|
|
Dual Task Questionnaire
Time Frame: 1 week
|
patient-reported questionnaire used to measure dual-task performance
|
1 week
|
|
Parkinson Activity Scale
Time Frame: 1 week
|
a scale to assess patients' mobility and transfers
|
1 week
|
|
Mini-Mental State Examination
Time Frame: 1 week
|
a short questionnaire giving information about the cognitive status of the patients
|
1 week
|
|
Freezing of Gait Questionnaire
Time Frame: 1 week
|
a scale questioning the frequency of freezing and freezing qualities in walking
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 13, 2024
Primary Completion (Actual)
January 1, 2025
Study Completion (Actual)
January 10, 2025
Study Registration Dates
First Submitted
January 13, 2025
First Submitted That Met QC Criteria
March 11, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 11, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MarmaraU-SANLI-ERSOZ-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaNot yet recruitingParkinson Disease | PARKINSON DISEASE (Disorder) | Parkinson Disease (PD), Postural Balance
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
Clinical Trials on Dual Task Impact on Daily-living Activities Questionnaire
-
Hospices Civils de LyonCompletedAmbulatory Care | Emergency Service, Hospital | Health Services for the AgedFrance
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinNot yet recruitingLocalized, Operable Non-small Cell Lung CancerFrance
-
Universidade do PortoRISE Study Group; Hospital de Sao Joao, PortoCompletedCerebral Vascular Accident (CVA)/StrokePortugal
-
Çankırı Karatekin UniversityNot yet recruitingAutism Spectrum Disorder (ASD) | Intellectual Disability, Variable
-
Assistance Publique - Hôpitaux de ParisORIXHARecruitingCardiac Arrest (CA) | Resuscitated Sudden Cardiac Death | Post Cardiac Arrest Patient Who Was Treated by Hypothermia ProtocolFrance
-
Hungarian Institute of CardiologySemmelweis UniversityUnknownQuality of Life | Aortic Valve Stenosis | Heart Valve DiseaseHungary
-
Washington University School of MedicineEdward P. Evans FoundationRecruitingCardiovascular Diseases | Aged | Geriatrics | Geriatric SyndromesUnited States